• Cullinan Oncology completes $98.5m Series B financing pharmaceutical-business-review
    June 09, 2020
    C​ullinan Oncology, LLC announced today the closing of a $98.5 million Series B financing, which will be used to support ongoing clinical trials across its small molecule and biologics portfolio.
PharmaSources Customer Service